January 22, 2019
USADA announced today that Cory Scott Juneau, of Westlake Village, Calif., an athlete in the sport of skateboarding, has accepted a six-month suspension for an anti-doping rule violation.
Juneau, 19, tested positive for 11-nor-9-carboxy-tetrahydrocannabinol (Carboxy-THC), a urinary metabolite of Δ9-tetrahydrocannabinol (THC), the main psychoactive constituent of marijuana and/or hashish, above the urinary Decision Limit of 180 ng/mL, as a result of a urine sample collected in-competition at the Oi Park Jam in Brazil on January 28, 2018, by the Brazilian Anti-Doping Agency (Autoridade Brazileira de Controle de Dopagem). Marijuana and hashish are Specified Substances in the class of Cannabinoids and prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, which has adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
The Brazilian Anti-Doping Agency transferred results management of the case to USADA in October 2018, with Juneau’s consent. Thereafter, Juneau accepted a six-month period of ineligibility that began on January 28, 2018, the date his positive sample was collected. Based on Juneau’s successful completion of a USADA anti-doping educational tutorial, his period of ineligibility was reduced by three months and expired on April 28, 2018. In addition, Juneau has been disqualified from competitive results obtained on and subsequent to January 28, 2018, including forfeiture of any medals, points and prizes.
Athletes are advised that the use of a substance or medication out-of-competition, that is prohibited only in-competition, may result in an anti-doping rule violation if the prohibited substance is still present in their body when tested at a competition. USADA cannot predict the clearance time for any substance for any particular individual. If an athlete needs to therapeutically use a substance prohibited in-competition and they are nearing a competition, they are strongly encouraged to contact USADA to learn if they need a Therapeutic Use Exemption (TUE).
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements (www.Supplement411.org) as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, an athlete handbook, and periodic alerts and advisories.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at email@example.com, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.